NEWS

Pharmaceutical

Roche: – Uhørt fra Beslutningsforum

Business

Category: Health

– Vi er bekymret over at norske MS-pasienter må ta til takke med legemidler som er utviklet for andre lidelser enn MS, bare fordi det er billigere, sier Roche-direktøren etter at Ocrevus fikk nei. – Dette er en trist dag for norske MS-pasienter. Ocrevus er den første medisinen som i betydelig grad bremser utviklingen av […]

Source: Dagens Medisin


More

Ny MS-medisin kan bli innført mandag

Business

Category: Health

Etter flere utsettelser skal Beslutningsforum mandag avgjøre om MS-medisinen okrelizumab (Ocrevus) kan tas i bruk ved norske sykehus. I januar i år ble okrelizumab (Ocrevus) godkjent til behandling av både attakkvis og progressiv multippel sklerose (MS) i Norge, men myndighetene har nølt med å ta legemiddelet i bruk. Statens legemiddelverk (SLV) ferdigstilte sine hurtige metodevurderinger […]

Source: Dagens Medisin


More

International Leadership Interview: Lena Nymo Helli, General Manager, AbbVie

AmCham

Category: AmCham Norway

“As a leader, rather than saying, “This is how you do this,” I try to encourage people to think how they want to solve it. “ Upon having completed her pharmacist degree, Lena Nymo Helli was always determined that she wanted to work in the pharmaceutical industry. Passionate about people, innovation and collaboration, she is […]

Source: AmCham


More

Merck (MSD) place second on Furtune’s “Change the World” List

Business

Category: Health

The timing was tragic. Merck embraced a vital mission in 2014 when it began developing an Ebola vaccine in collaboration with Canada’s public health agency and NewLink Genetics, not long after the deadly virus broke out in West Africa. Effective vaccines take months to create, and by the time V920 could be deployed, the disease had claimed […]

Source: Fortune


More

AmCham’s Arendalsuka Debate: The Pharmaceutical Industry Revealed

Category: AmCham News

According to data from Apeland and Norstat, only 5% of the population in Norway considers the pharmaceutical industry to be trustworthy, with only 52% of Norwegian survey respondents reporting any familiarity with the industry at all. With these statistics as a starting point, a panel consisting of senior representatives from the pharmaceutical industry, politicians and […]

Source:


More
Page 3 of 5
1 2 3 4 5